Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Small-molecule antioxidant patent granted

Sep. 12, 2000

Transgenic pig cells restore impulse conduction in injured rat spinal cord

Sep. 12, 2000

NK1 receptor antagonist may be useful for treatment of chronic pain

Sep. 12, 2000

Potential antipsychotics patented by MS&D

Sep. 8, 2000

A series of dual 5-HT1A antagonists and 5-HT reuptake inhibitors described by Lundbeck

Sep. 8, 2000

Inosine produces significant recovery of limb function in rat model of stroke

Sep. 8, 2000

Lundbeck and Mitsui establish citalopram collaboration agreement

Sep. 7, 2000

Meiji Seika describes inhibitors of PARP and their use in recent patent

Sep. 7, 2000

Potential therapeutic agents for pain identified by AstraZeneca

Sep. 6, 2000

Anticonvulsants for cluster headache

Sep. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...